Teckro platform can be applied to any type of clinical trial, including the decentralized approaches that have become increasingly prevalent during the COVID-19 pandemic, helping enhance communication among stakeholders and improve sponsor visibility, even under challenging conditions.

For clinical trials, extra retention efforts need to be applied selectively, since these can add significant cost and take up study coordinators’ time.

Jeanne Hecht and Teckro's Malia Lewin reflect on what sustainability means in clinical research and the impact of Teckro, including how more streamlined communications leads to less travel, more trial efficiency, and a greener approach.

The COVID-19 pandemic has caused life sciences organizations to adjust to supply chain and clinical development disruptions that would have previously been unthinkable. This podcast delves into questions of how the pandemic has impacted the life sciences - How to deliver products and innovative discoveries to patients? Are we stopping the clinical trials of all other therapeutics?